Suppr超能文献

肝细胞对组织型纤溶酶原激活剂(t-PA)的受体介导内吞作用。

Receptor-mediated endocytosis of tissue-type plasminogen activator (t-PA) by liver cells.

作者信息

Rijken D C, Otter M, Kuiper J, van Berkel T J

机构信息

Gaubius Institute TNO, Leiden, The Netherlands.

出版信息

Thromb Res Suppl. 1990;10:63-71. doi: 10.1016/0049-3848(90)90379-q.

Abstract

Tissue-type plasminogen activator (t-PA) has a short half-life in the circulation because the enzyme is rapidly cleared by the liver. This short review summarizes recent literature concerning mechanisms of uptake and degradation of t-PA in the liver. In vivo studies in rats show that degradation takes place via a lysosomal pathway. Saturation of the uptake system at high t-PA concentrations suggests a receptor-mediated mechanism. Competition experiments with various glycoproteins indicate that the asialoglycoprotein receptor is not involved, but they point to a role for the mannose receptor, which recognizes t-PA via its high mannose-type oligosaccharide on the first kringle domain. Both in vivo and in vitro studies with isolated liver cells demonstrate that parenchymal cells, as well as liver endothelial cells, are involved in the clearance of t-PA. Parenchymal cells, as the hepatoma cell line Hep G2, endocytose t-PA via a still unknown, possibly t-PA specific receptor, while liver endothelial cells catabolize t-PA via the mannose receptor.

摘要

组织型纤溶酶原激活剂(t-PA)在循环系统中的半衰期较短,因为该酶会被肝脏迅速清除。这篇简短综述总结了近期有关肝脏中t-PA摄取和降解机制的文献。对大鼠的体内研究表明,降解通过溶酶体途径进行。在高t-PA浓度下摄取系统的饱和表明存在受体介导的机制。与各种糖蛋白的竞争实验表明,去唾液酸糖蛋白受体不参与其中,但这些实验指出了甘露糖受体的作用,该受体通过其在第一个kringle结构域上的高甘露糖型寡糖识别t-PA。对分离的肝细胞进行的体内和体外研究均表明,实质细胞以及肝内皮细胞都参与了t-PA的清除。实质细胞,如肝癌细胞系Hep G2,通过一种仍未知的、可能是t-PA特异性受体对t-PA进行内吞,而肝内皮细胞则通过甘露糖受体分解代谢t-PA。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验